UK markets open in 4 hours 51 minutes

Neovacs S.A. (0W8U.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.0070-0.0032 (-31.51%)
At close: 4:55PM BST
Currency in EUR

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 31.83M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3174.60
Enterprise value/EBITDA 7-0.35

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3N/A
S&P500 52-week change 337.70%
52-week high 30.0070
52-week low 30.0070
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 176.16M
% held by insiders 10.22%
% held by institutions 10.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-51,010.30%

Management effectiveness

Return on assets (ttm)-59.24%
Return on equity (ttm)-1,479.08%

Income statement

Revenue (ttm)10.5k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-5.3M
EBITDA -5.3M
Net income avi to common (ttm)-10.2M
Diluted EPS (ttm)-0.0570
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)210.64k
Total cash per share (mrq)0
Total debt (mrq)62.32k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.27
Book value per share (mrq)-0.02

Cash flow statement

Operating cash flow (ttm)-4.99M
Levered free cash flow (ttm)1.85M